REVIEW PAPER: pathology of animal models of alphavirus encephalitis.

The research article explores the implications of animal models as part of efforts to understand and develop countermeasures against encephalitis diseases caused by Venezuelan (VEEV), eastern (EEEV), western (WEEV) equine encephalitis viruses in horses and humans. The paper zeroes in on the pathology of these illnesses and pathogenic mechanisms in animal models particularly, when it involves aerosol infections.

Focus of the Research

• The research primarily targets to comprehend the pathology of encephalitides in animal model mainly caused by VEEV, EEEV, and WEEV viruses.
• The study emphasizes the need for well-characterized animal models that can aid the development of medical countermeasures, given there are no licensed vaccines or specific therapies available currently for prevention or treatment of these infections.

Animal Model Significance

• Through animal models, the process of infection caused by VEEV, EEEV, and WEEV viruses can be closely studied, leading to observation of symptoms such as encephalitis and often death.
• The study notes the high degree of variability in disease manifestations amongst different animal models.

Avenues for Further Research

• The research calls for improved characterization of the disease in animal models as well as in humans using modern methodologies. This shows the need for further investigation and research in this domain.
• The authors insist on a better understanding of three phases in the pathogenesis of alphavirus encephalitis – the early extraneural phase, neuroinvasion process, and factors relating to neurovirulence derived from the virus and host.

Potential Impact of Research

• Gaining deeper understanding of disease mechanisms could potentially pave way for the development of medical countermeasures.
• The findings could help establish proper animal models for alpha virus encephalitis, thus providing a reliable platform for testing potential countermeasures as per the “Animal Rule” regulations set by the United States Food and Drug Administration.